“…The first involves drug-eluting structures formulated with anti-inflammatory drugs [21,22,23,24,25] and neurotrophin-eluting hydrogels [26,27,28,29,30,31]. The second approach involves integration of microfluidic channels into neural prostheses for in situ delivery of bioactive molecules with high temporal and spatial resolution [32,33,34,35,36,37,38,39]. Finally the use of organic conductive polymer (OCP) coatings, a novel class of materials that significantly decrease the impedance of electrodes, and also can provide controlled delivery of bioactive molecules at the electrode-neural interface [40,41,42,43,44,45,46,47,48,49,50].…”